The global market for new chemical entity (NCE) CDMOs is expected to grow from approximately US$3.172 billion in 2025 to approximately US$6.817 billion in 2032, representing a projected CAGR of 11.8%.
This release announces the publication of a research report on the global market for new chemical entity (NCE) CDMOs. The global market is projected to grow from approximately US$3.172 billion in 2025 to approximately US$6.817 billion in 2032, with a CAGR of 11.8% expected from 2026 to 2032.
The market is segmented by type into peptide NCEs, oligonucleotide NCEs and Other, and by application into oncology, cardiovascular disease and Other. Regional segments include the Americas, APAC, Europe, and the Middle East and Africa.
The major global players include KATSURA CHEMICAL CO., LTD, Regis Custom API, Neuland Laboratories Ltd., Aspen API and Sai Life Sciences. The market share of the leading companies in 2025 is also discussed. LPI's report is cited as the basis for the background and forecasts in this study.
The report includes detailed analyses by product type, application and region, as well as forecasts for 2027 to 2032, trends among major companies, growth factors and challenges.